Skip to main content

Table 1 Primary and secondary outcome parameters

From: A prospective multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART Disc plus autologous disc chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disc to avoid secondary disease: study protocol for a randomized controlled trial

Primary outcome parameter

Oswestry Disability Index (ODI), German and Austrian version, at 5 years’ follow-up to measure degenerative lumbar disc-related disability. [11, 12]

Secondary outcome parameter

Changes in health status and quality of life will be captured by the Short Form-36 (SF-36) version 2.0 questionnaire [14] and EuroQuality of Life 5-Dimension-3 L (EQ-5D-3 L) questionnaire [13]

Pain relief, as defined by improvement on 100 mm visual analog scale for back and leg pain [15].

Index level and adjacent disc on magnetic resonance imaging (MRI)

• by evidence of disc degeneration (Pfirrmann Classification) or osteochondrosis (Modic Changes) [3032]

• by numerical measurements in disc high, volumetry, and signal intensity

• by T2 relaxation

• by the presence or absence of stenosis.

Pain medication usage will be assessed by a four-level score (0 = none to 3 = high level of usage).

Work status and time to return to work

Neurological status will be evaluated using the Jenny Scale as a neurological test for the lower extremities, including motor and sensory deficits, reflexes, sciatic stretch ability and walking range.

Functional status:

• by posture and gait

• by finger-ground distance

• by Schober’s sign

• by precision tenderness/pressure pain